Abington Heights girls basketball team winning streak highlights weekly sports roundup

Lions edge Comets on the mat

Lackawanna Trail defeated Abington Heights, 34-30, in a nonleague wrestling match on Jan. 28 in South Abington Twp. T0m Kohinsky (126) and Tyler Baltrusaitis (145) won by pin for the Lions. DJ Klinges (160) won by major decision, Rocco Pacini (170) and Nathaniel Barbolish (220) won by decision and Trent Ashley (138) and Jordan Hannon (285) won by forfeit. Jimmy Fayocavitz (132), Nick Carr (152) and Anthony Sylvester (195) won by pin for the Comets. Luke Fayocavitz (113) and Zach Spangenberg (182) won by decision and Noah Sirianni (106) won by forfeit.

Cavs, Classics victorious in the pool

The Scranton Prep boys swim team defeated Elk Lake, 110-56, in a Lackawanna League meet on Jan. 27 at The University of Scranton. Joe Kyle Bushta had wins in the 200 free and 100 back. Tom Pfaeffle won the 200 individual medley, Nico Lastauskas had wins in the 50 free and 500 free, Ryan Sebastianelli placed first in the 100 free and Ben Evans won the 100 breast. The Prep 200 medley (Sebastianelli, Lastauskas, Bushta and Richie Holden), 200 free (Conor McCall, Mike Terrery, Mike Robinson, and Sebastianelli), and 400 free (Lastauskas, Pfaeffle, Holden and Ryan Powell) teams also placed first.

The Scranton Prep girls swim team downed Elk Lake, 88-73. Cat Donlon had wins in the 200 individual medley and 100 fly, Katie Voitik placed first in the 100 free and 100 breast. The Classics also placed first in the 200 medley (Emily Donlon, Cat Donlon, Lauren Lanzendorfer and Catherine Dipaolo), 200 free (Cat Donlon, Mariah Leontopoulou-Cochran, Voitik and Audrey Campo), and 400 free (Voitik, Campo, Emily Donlon Lanzendorfer) relay events.

Comets, Lady Comets swim past West

The Abington Heights boys swim team defeated West Scranton, 123-57, in a Lackawanna League meet on Jan. 27 in South Abington Twp. Ben Vale had wins in the 500 free and 100 breast, Shane Cummings places first in the 200 free, DJ Weiland won the 200 individual medley, Max Voyce placed first in the 100 fly, Noah Shapiro won the 100 free and Sam Jubon placed first in the 100 back. The 200 medley (Brendan Conahan, Shapiro, Voyce0 and Andrew Barren) 200 free (Barren, Jubon, Cummings and Shapiro), and 4o0 free (Chris Suh, Barren, Shapiro and Vale) teams also had wins.

The Abington Heights girls swim team downed West Scranton, 139-39. Danielle Sanok had wins in the 200 individual medley and 100 breast, Catherine Simakaski placed first in the 200 free, Hannah Conahan won the 50 free, Rachel Smertz placed first in the 100 fly, Kelsey Jackson won the 100 free, Leah Byman placed first in the 500 free and April Sokalsky won the 100 back. The Lady Comets also placed first in the200 medley (Smertz, Laura Hartman, Byman Sydney Gualtieri), 200 free (Hartman, Gualtieri, Byman, Smertz), and 400 free (Smertz, Hartman, Gualtieri Byman) relay events.

Comets top Cougars, rout Buckhorns on the court

Clay Basalyga scored a game-high 13 points to lead Abington Heights to a 49-33 win over Valley View in a Lackawanna League Division 1 boys basketball game on Jan. 27 in Archbald. Jordan Hollander and Tim Toro each added nine for the Comets.

Read this article:

Abington Heights girls basketball team winning streak highlights weekly sports roundup

Psoriasis Revolution Review and Bonus – Skin Clearing, Holistic Holy Grail? – Video


Psoriasis Revolution Review and Bonus - Skin Clearing, Holistic Holy Grail?
Psoriasis Revolution Bonus and Review - http://prominentoffers.com/skin-care-recommendations/psoriasis-revolution-review/ http://psoriasisrevolution.co Psori...

By: ProminentOffers

Read the original here:

Psoriasis Revolution Review and Bonus - Skin Clearing, Holistic Holy Grail? - Video

Super Lutein Testimonials – Psoriasis Natural Remedies / Treatment that Works +65 9652 6095 – Video


Super Lutein Testimonials - Psoriasis Natural Remedies / Treatment that Works +65 9652 6095
http://www.superluteinsingapore.com/ Super Lutein Testimonials - Psoriasis Natural Remedies / Treatment that Works. Call +65 9652 6095 for Trial Offer Took Super Lutein and Izumio Recovered...

By: PropertyAgentSgp

The rest is here:

Super Lutein Testimonials - Psoriasis Natural Remedies / Treatment that Works +65 9652 6095 - Video

Psoriasis Is an Auto-Immune Disease That Causes Itching and Rashes

Psoriasis causes skin cells to build up rapidly on the surface.

Imagine a disease that is hiding in your genetic makeup, waiting for some external event to trigger it into existence.

When activated, this disease convinces your body that something is wrong with your own skin, causing a life-long struggle that culminates in itching, uncomfortable, embarrassing rashes that can be painful, hard to treat and impossible to cure.

Nearly 3 percent of the world's population has no need to imagine such a disease to them it is a very real ailment called psoriasis.

Psoriasis is a genetic auto-immune disease that causes skin cells to build up rapidly on the surface, creating extra-thick skin that can present itself as anything from silvery scales to red, itchy, dry patches.

Patients who have psoriasis are also predisposed to develop psoriatic arthritis, causing pain, stiffness and swelling of their joints.

No one knows exactly why psoriasis happens, but genetics, environmental factors and the immune system all figure into it. The condition is not contagious.

Certain events have been linked to triggering the condition into activity. Scientists have not discovered the direct connection but they agree that genetics are definitely involved. Of every three people with psoriasis, one will know a relative with the disease.

Amanda Jackson of Lakeland said, "My dad and his mother had it it is hereditary and not contagious, not at all." Jackson and two of her six children have it as well.

Environmental factors such as stress, injury to skin, infection, certain medications, smoking, heavy alcohol consumption, diet and allergies, can act as triggers to turn on the disease. After the initial outbreak, triggers can also cause flare-ups in the psoriasis cycle.

More:

Psoriasis Is an Auto-Immune Disease That Causes Itching and Rashes

World's biggest travel rush under way

*The world's most populous country kicked off its largest seasonal travel rush on Wednesday.

*China's rail system is expected to handle 300 million trips during the travel rush, up 10 pct from last year.

*The travel spree, known as "Chunyun" in Chinese, is considered the world's largest human migration.

Passengers wait for the departure of train 3805 from Guangzhou, capital of south China's Guangdong Province, to Chongqing, southwest China, Feb. 4, 2015. The 40-day travel frenzy known as "chunyun", the hectic period through the Chinese lunar New Year, or the Spring Festival, which falls on Feb. 19 this year, began on Feb. 4 and will last until March 16. Train 3805 is the first chunyun train from Guangzhou. (Xinhua/Wang Shen)

The world's most populous country kicked off its largest seasonal travel rush on Wednesday with an expected 2.8 billion trips during the 40-day Lunar New Year holiday season.

Taking place annually fourteen days ahead of the Spring Festival holiday, the travel spree, known as "Chunyun" in Chinese, is considered the world's largest human migration, with hundreds of millions of Chinese people traveling home to reunite with family.

This year's number of trips would be 3.4 percent higher than that of last year, according to official estimation.

RAILWAY TRAVEL

China's rail system is expected to handle 300 million trips during the travel rush, up 10 percent from last year. It represents the highest growth of all forms of passenger transportation, according to figures from the National Development and Reform Commission.

Go here to read the rest:

World's biggest travel rush under way

Supermicro Highlights Ultra, TwinPro, and FatTwin SuperServer Platforms Optimized for VMware vSphere 6 and Virtual …

-- Server and Storage Platforms Accelerate Deployment of Hyper-Converged Infrastructure for Hyperscale, SDDC, IaaS and Public, Private Cloud Service

SAN JOSE, California, Feb. 2, 2015 /PRNewswire/ --Super Micro Computer, Inc. (NASDAQ: SMCI), a global leader in high-performance, high-efficiency server, storage technology and green computing will highlight its broad range of server, storage and networking platforms optimized for hyper-converged infrastructure at VMware Partner Exchange 2015 this week in San Francisco, CA. New solutions are configured to take maximum advantage of VMware vSphere 6 and VMware Virtual SAN 6 functionality delivering turnkey solutions that accelerate deployment and ease management and maintenance of hyper-scale virtualized environments. Headlining the company's exhibits will be the 1U/2U Ultra series SuperServers for general purpose virtual compute, 2U TwinPro VMware EVO: RAIL appliance, 4U FatTwin Virtual SAN Ready Nodes, and 2U vGPU-capable High-Speed Ultra Server featuring up to 4x NVIDIA GRID K2 GPUs. The 7U VMware certified SuperBlade, supporting up to 30x hot-swap NVMe or 20x NVIDIA GRID K2 GPUs, will also be highlighted, including a blade-based direct-attached JBODs solution, managing externally connected disk enclosures for leveraging existing investments in blade-based architectures.

"Supermicro is defining the next generation hardware platform for hyper-converged infrastructure with the widest range of compute and storage platforms optimized for any specific virtualization application," said Charles Liang, President and CEO of Supermicro. "Our Ultra, TwinPro, FatTwin and SuperBlade solutions feature Intel Xeon E5-2600 v3 CPUs, DDR4, hot-swap NVMe, virtualized GPUs and high efficiency digital power supplies. They are ideal for Virtual SAN hybrid or all-flash deployments. With their unique characteristics, they improve data center performance, bring down overall TCO and future-proof customer investments in hyper-converged infrastructure deployments for SDDC, IaaS and Public Private Cloud services environments."

"With the release of VMware vSphere 6 and VMware Virtual SAN 6 we completed two major steps forward in the realization of our vision for the software-defined data center, enabling the next generation of hyper-converged infrastructure," said Todd Surdey, vice president, Strategic Alliances and Emerging Partners, VMware. "Supermicro is focused on bringing the latest technologies to market fully tested and validated for our hyper-converged infrastructure solutions. Through strategic partnerships, we can deliver a complete virtualized compute, storage, network, and management platforms featuring increased performance and scalability to support our mutual customers' most challenging business-critical applications."

Photo - http://photos.prnewswire.com/prnh/20150131/172684

Product Highlights

Visit Supermicro at VMware Partner Exchange in San Francisco, CA, February 3-5 at Moscone Center West. For more information on Supermicro's complete range of high performance, high-efficiency Server, Storage and Networking solutions, visit http://www.supermicro.com.

Follow Supermicro on Facebook and Twitter to receive their latest news and announcements.

About Super Micro Computer, Inc. Supermicro (NASDAQ: SMCI), the leading innovator in high-performance, high-efficiency server technology is a premier provider of advanced server Building Block Solutions for Data Center, Cloud Computing, Enterprise IT, Hadoop/Big Data, HPC and Embedded Systems worldwide. Supermicro is committed to protecting the environment through its "We Keep IT Green" initiative and provides customers with the most energy-efficient, environmentally-friendly solutions available on the market.

Supermicro, Building Block Solutions and We Keep IT Green are trademarks and/or registered trademarks of Super Micro Computer, Inc.

Originally posted here:

Supermicro Highlights Ultra, TwinPro, and FatTwin SuperServer Platforms Optimized for VMware vSphere 6 and Virtual ...

Florida Panther Receives Cutting Edge Stem Cell Procedure from MediVet Biologics

Nicholasville, KY (PRWEB) February 04, 2015

Rescued when he was only 4 weeks old, Nakiia, a 15-year-old Panther, has been living in severe pain after a jumping incident. Jan Hall, Nakiias owner has dedicated her life to rescuing animals. Nakiia, the namesake of her rescue foundation The Nakiia Foundation is the love of her life. Witnessing this fabulous animal in such pain was too much for Jan to bear. The Doctors treating Nakiia decided to undertake a revolutionary medical procedure, which centers on regenerative medicine.

Newman Veterinary Center in DeLand Florida performed MediVets Adipose (fat)-derived stem cell therapy. The male Florida panther underwent this procedure, more commonly performed on domestic animal such as dogs, cats and horses. The procedure is an effort to ease the pain from severe arthritis in his joints. This was a last stage effort for the panther that can no longer continue to live in such pain.

Though stem cell treatments have been performed in exotic animals before, it is still a rare and exciting undertaking. Utilizing MediVet Biologics procedure, Dr. Ted Oliver was able to ensure the process will produce the best possible results. MediVets procedure is completed in one day and in-clinic.

Stem Cell treatments in the past have often been controversial when embryonic cells where involved, with adipose or fat tissue Nakiias own adult stem cells could be easily concentrated and activated with minimal risk. Until recently Veterinarians only had the option of utilizing outside labs for processing of autologous cells, with the one step surgical treatment available from MediVet Biologics, Veterinarians all around the country can eliminate the costs and variability in shipping by utilizing an onsite simple procedure.

During the procedure, Dr. Oliver removed about four tablespoons of belly fat from the panther. The fat was then processed in-clinic by a trained technician. The cells are incubated, isolated and activated by a patented process. Dr. Oliver carefully re-administered the cells directly back into Nakiia. Nakiias excess cells will be stored for future use eliminating the need to surgically re-harvest additional tissue.

MediVets primary mission and goal is to help all animals live a pain free life. In regenerative medicine and biologic intervention age is not a disease rather a challenge that presents us many opportunities to develop cutting edge treatments to combat issues related to the aging process. Our partnerships with progressive Veterinarians such as Newman Veterinary Centers allow us to extend affordable cutting edge treatments to animals who otherwise potentially have limited treatments available. We look forward to following Nakiias progress." - Jeremy Delk, CEO of MediVet Biologics.

Newman Veterinary Center was honored to be a part of Nakiias stem cell procedure. The excitement that this 146-lb. cat brought to our clinic was unparalleled. We have very high hopes that Nakiia will be feeling much better very soon. - Erica Kent Director of Operations at Newman Veterinary Centers.

Nakiias story will air on Wednesday, February 4th on CBS WKMG (local 6) with Mike Holfeld, Investigative Reporter.

About MediVet Biologics MediVet Biologics is the Worlds leading provider of Veterinary regenerative medicine. The central Kentucky based company was founded in 2009 and quickly gained favor in the Veterinary industry with the advent of in-clinic adipose derived stem cell and platelet rich plasma treatments. Since gaining wide appeal in the small and large veterinary market MediVet Biologics has developed a strong biologic pipeline that includes, among other cutting edge treatment options, patient specific immunotherapy services.

See the original post:

Florida Panther Receives Cutting Edge Stem Cell Procedure from MediVet Biologics

Okyanos Cell Therapy Success Brings Hope for a Normal Life

Freeport, Grand Bahama (PRWEB) February 04, 2015

In just a few short months since Okyanos opened its doors, remarkable results are becoming a daily reality. In light of these mounting successes, Okyanos, the leader in cell therapy, has augmented its adult stem cell therapy for severe heart disease and expanded their offerings to include treatments for patients with other chronic unmet needs. Now, patients like Patsy and Dylan are experiencing the tangible benefits that Okyanos cell therapy provides.

Patsy, 72 years old, lived a normal life until 2012 when a diagnosis of congestive heart failure (CHF) put a halt to her active lifestyle. Patsys health quickly deteriorated. Despite open heart surgery, a pacemaker and medications, all were insufficient to arrest her physical decline. Faced with a heart transplant as her next option and fearful of the idea, Patsy began searching for another alternative.

I was looking at going to Mexico, and my cardiologist was talking to me about being a part of a clinical trial where they inject two different kinds of drugs into the heart, but I was hesitant about that idea and worried I would get the placebo. A friend knew I had a heart problem, and she recommended Okyanos.

Patsys arrival at Okyanos quickly allayed any apprehension as she said, I couldnt ask to be treated any better than if they were my own sisters or brothers. It was truly amazing. You just dont get that kind of care in regular hospitals.

After just a few short months since her mid-October (2014) treatment with Okyanos cell therapy, Patsy is noticing improvements. Im doing better. I can already tell the difference. Im getting up the stairs more easily. Im doing the laundry again. I have more energy, and when you have more energy and you feel better, your point of view on life is betterit really makes a big difference.

Dylan is another success. At 16, Dylan had dreamt of a career playing tennis but began experiencing extreme pain with his hips locking up, causing him to fall to the ground. He was diagnosed with a rare condition that causes abnormal growth of tissue lining the joints that can later break off and damage cartilage. After 2 surgeries to clean out his hips, constant pain and an inability to walk without a limp, run or bend over, the condition worsened. After speaking with doctors, it was clear that continuation of regular surgeries would further deteriorate Dylans hips. Determined to see her son walk normally, Dylans mother discovered Okyanos and both decided to move forward with cell therapy.

Dylan underwent cell therapy wherein stem cells were separated from his own fat tissue for direct injections into the hip as well as delivery by IV to address underlying causes of ischemia, inflammation and abnormal immune response. Ten days later, Dylan was pain-free and able to walk normally, run and bend over.

Im pinching myself. Its amazing. No, its miraculous! says Elena about her sons recovery. If Dylan had not had the cell therapy, we would have kept doing other treatments and crossed our fingers. At 20 years old, his future would have been hip replacement surgery and a lifetime of problems walking, painful movement and an inability to bend down.

Stem cell therapy is a relatively simple and minimally-invasive same-day procedurea stark contrast from open heart surgery or hip surgeryyet offers patients the hope of a more normal life. Patients like Patsy concur, Its going to give people hope. And give them a life. You get to a point with a body where you push and push and run out of energy. Thats not really life to me. I think stem cell therapy can give back life.

Go here to read the rest:

Okyanos Cell Therapy Success Brings Hope for a Normal Life

International Stem Cell completes cell bank manufacturing for Parkinson's disease clinical trial

Published 04 February 2015

International Stem Cell, a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, announced that the company has completed manufacturing of the cell bank of clinical-grade human neural stem cells using its patented process for the recently announced phase 1/2a clinical trial in Parkinson's disease.

The cell bank contains over 2.6 billion human cells, sufficient to meet the company's foreseeable clinical trial requirements.

"Completing the production of clinical-grade cells using the previously published protocol is one of the final steps before starting our clinical program," said Ruslan Semechkin, Ph.D., ISCO's Chief Scientific Officer.

"Because of the complexity involved in manufacturing live human cell products, having our own GMP facility is not only a strategic advantage, but also allows us to control the production costs. We continue to anticipate, subject to regulatory agency approval, beginning the clinical trial in early 2015 and will provide a further update in the near future."

ISCO's master cell bank of human parthenogenetic neural stem cells (ISC-hpNSC) is produced in compliance with current good manufacturing practices (cGMPs) and the chemistry and manufacturing controls (CMC) discussed in the previously reported pre-IND meeting with the FDA. The cells are karyotypically normal hpNSCs and free of measurable contaminants of human or animal origin.

The production of hpNSCs from undifferentiated pluripotent human parthenogenetic stem cells in the master cell bank uses qualified reagents and a standardized protocol developed by ISCO. The undifferentiated human stem cells are derived from the parthenogenetic line and were recently cleared by the FDA for use in clinical trials.

Each batch of hpNSC is subjected to standardized quality control testing to ensure viability, sterility and appropriate cellular composition before clinical use. The existing master cell bank and current production scale are sufficient to supply our anticipated product needs through pivotal clinical trials. The cell bank was produced at the company's state of the art GMP manufacturing facility located in Oceanside, Calif.

ISC-hpNSCs are a novel therapeutic cellular product derived from the Company's proprietary human pluripotent stem cells. Neural stem cells are self-renewing multipotent cells that are precursors for the main cell types of the central nervous system.

The ability of ISC-hpNSCs to differentiate into dopaminergic neurons and express brain-protecting neurotrophic factors offers a new opportunity for the treatment of Parkinson's disease. ISCO's preclinical program includes animal studies to assess the safety and tolerability of our novel cell therapy as well as doses ranging efficacy to be used to design the first clinical trial in Parkinson's disease patients.

The rest is here:

International Stem Cell completes cell bank manufacturing for Parkinson's disease clinical trial

Howe to Assist Dementia Fundraiser

Gordie Howe has made such a dramatic recovery after having stem cell therapy in December in Tijuana, Mexico, that hes heading to Saskatoon, Saskatchewan, this weekend for a dementia fundraiser involving Wayne Gretzky.

The Kinsmen Arena there will be renamed the Gordie Howe Kinsman Arena.

Murray Howe raced from Toledo, Ohio, to Lubbock, Texas, in late October, unsure whether his father, who had suffered a massive stroke, would still be alive when he got there. The Detroit Red Wings hockey legend was being cared for by his daughter, Cathy, and family members were advised to get there quickly if they wanted to see him again.

Murray Howe told the Free Press in a telephone interview Tuesday he was heading back to Lubbock today to help accompany his father, along with other family members, to Saskatoon for the public appearance.

Gordie Howes younger brother, Vic, who played for the New York Rangers, died Saturday at age 85 in Moncton, New Brunswick. Murray Howe said Gordie would not be able to attend his brothers funeral, but would be with two sisters, Helen and Vi, while in Saskatoon, and the family would gather there for a memorial service for their brother.

Although the event in Saskatoon had been planned for more than a year, the Howe family told organizers in August that Gordie probably wouldnt be able to attend because of declining health. They definitely didnt think hed be able to attend following a series of strokes that he had in the months that followed.

But Howe has made a drastic recovery, to the point that family members told the organizers if theres an extra chair for him, he thinks he can make it.

Murray Howe said he was very skeptical when representatives from Stemedica reached out a following the news of Gordie Howes massive stroke.

Stem cells werent even on my radar, Murray Howe said, who did a bunch of research before his father agreed to pursue the therapy.

Stemedica has a stem cell trial in the U.S., but patients have to wait six months following their stroke before they can begin to the therapy. The stem cell trial by Novastem at Clinica Santa Clarita in Mexico did not require a six-month wait.

The rest is here:

Howe to Assist Dementia Fundraiser